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ABSTRACT 
When local or general predisposing factors are present, Candida, an oral 
opportunistic pathogen, may cause acute or chronic oral infections. It is well known that 
healthy individuals differ with respect to the carrier status of Candida a/bicans. The aim 
of this project was to determine Candida carriage among healthy individuals, and to 
investigate the spectrum of antifungal activity of parotid secretion. To determine the 
oral Candida carrier status, masticatory stimulated whole saliva (WS) was collected 
from thirteen healthy subjects, every 2 to 3 days, during a 2 week time interval. The cell 
sediment from 1 ml WS was suspended in 100 µI phosphate buffered saline (PBS, pH 
7.0) and plated on Sabouraud dextrose agar or on Chromagar to determine the 
number and type of fungi present in WS, respectively. Gustatory stimulated parotid 
secretions (PS) were collected from four of the thirteen subjects, two being low and two 
being high Candida carriers. The fungistatic activity of the collected PS secretions was 
evaluated in growth media assaying 15 medically important fungi including 6 strains of 
C. albicans. Four of the 13 subjects were found to be non-Candida carriers in WS (zero 
colonies on all sampling occasions), five were low carriers (zero to a few colonies 
cultured per occasion) and four were high carriers (never zero colonies, mostly double 
digit counts). The total number of C. albicans in the carriers showed considerable 
fluctuation, which was established to be due to the sampling occasion. However, non-
carriers maintained their non-carrier status during the entire interval of examination. PS 
collected from four of the thirteen subjects exhibited a surprising trend of being 
fungistatic toward many fungal species, as evidenced from the low IC50 values, while 
being 20-50 fold less active against the six evaluated strains of C. albicans. This was 
true for PS samples collected from low or high Candida carriers. Considering the fact 
that PS is a major contributor to oral fluid, this observation would suggest a lower 
IX 
overall antifungal activity in the oral cavity toward C. albicans in particular. It is 
hypothesized that this may be a contributing factor to the successful oral colonization 
of C. albicans. 
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1. INTRODUCTION 
1.1 Saliva Production 
Glandular salivary secretions are the most important fluid contributors to the 
oral cavity. Human saliva is secreted by three major salivary glands and many minor 
glands. The three major salivary glands are parotid, submandibular and sublingual 
glands which produce 90% of the bulk volume of whole saliva. The parotid salivary 
glands produce serous fluid secretions while the submandibular and sublingual glands 
produce mixed serous-mucin secretions. The minor glands contributions are about 
10% of the total saliva volume and are of palatine, buccal and lingual origin (Herrera et 
al., 1988). 
Each salivary gland is composed of three units. These are the acinus, the 
striated ducts, and the excretory ducts. The acinus is the secretory unit of the salivary 
gland. In the parotid glands, the acinus is lined by serious cells, in minor glands they 
are lined by mucous cells and in the submandibular and sublingual glands they are 
lined with both serous and mucous cells. Salivary components are secreted by acinar 
cells and flow through the striated ducts. The striated ducts are lined by cuboidal cells 
which contain many mitochondria. The cuboidal cells absorb sodium and chloride and 
secrete potassium and bicarbonate into the lumen. In contrast, the sublingual glands 
do not contain striated ducts and produce saliva with an osmotic pressure similar to 
that of plasma. Saliva is secreted from the striated ducts into the excretory ducts which 
then drain into the oral cavity. The excretory ducts further absorb the extra sodium and 
secrete potassium. Due to this ductal reabsorption process, saliva is hypotonic 
compared to serum. Furthermore, the ionic composition of saliva is influenced by the 
salivary flow rate (Dawes, 1969; Herrera et al., 1988). 
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The nonstimulated salivary flow rate varies during the day. Salivary flow is more 
pronounced in the afternoon as opposed to the morning and reaches near zero during 
sleep due to decreased physiological and other stimuli (McKenowen et al., 1959). 
Physical stimuli from the oral cavity and psychic stimuli from taste, smell, or sight travel 
along afferent pathways to the superior and inferior salivary nuclei located in the 
medulla. From these central nervous system centers, efferent pathways communicate 
with the salivary glands that lead to a salivary response (Lesson et al., 1967). During 
maximal stimulation, salivary secretion may reach 4 ml/min. The average daily output 
of saliva in healthy humans is estimated to vary from 1,000 to 1,500 ml/day. The pH of 
glandular saliva before secretion into the oral cavity is 5.5 to 6.6 and increases to 7.2 to 
7.6 after entering into the oral cavity due carbon dioxide loss upon contact with air 
(Herrera et al., 1988). 
1.2 Composition of Saliva 
Biochemical components of human saliva have been studied in great detail. 
The multiple antimicrobial components described above to be present in saliva are 
important considering the fact saliva contains a large number of bacteria and fungi. 
Saliva contains components that inhibit and neutralize the endogenous oral microflora 
and its many harmful metabolic products. It is composed of organic and inorganic 
constituents. Among the inorganic constituents are sodium, chlorine, bicarbonate, 
calcium, phosphate and urea. The organic composition of saliva is mainly accounted 
for by proteins. The major proteins are represented by praline-rich proteins (PRPs), 
statherin, mucin, cystatin, histatin, lysozyme, lactoferrin, peroxidases and slgA. The 
salivary proteins exhibit important functions pertinent to the maintenance of oral health, 
such as lubrication, antimicrobial activity, protection against demineralization and the 
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control of re-mineralization of teeth. (Lamkin et al., 1993; Schenkels et al., 1995; Dodds 
et al., 2005) 
1.2.1 Inorganic Composition of Saliva 
As indicated above sodium and chloride are reabsorbed in the ductal system of 
the salivary glands rendering saliva hypotonic. The low levels of these two minerals in 
saliva facilitate taste. Calcium and phosphate are important for the maintenance of 
tooth mineral integrity and bicarbonate allows buffering (Dodds et al., 2005). The 
buffering capacity of saliva is a very crucial function and it has been demonstrated that 
subjects with a low salivary buffer capacity are at a higher risk for caries development 
(Leone et al., 2001 ). 
1.2.2 Organic Composition of Saliva 
a. Proline-Rich Proteins (PRPs} 
Praline-rich proteins (PRPs) are produced by parotid and submandibular 
glands. Seventy percent of parotid proteins are composed of PRPs (Lamkin et al., 
1993). They contain an unusual high number of praline, glycine and glutamine residues 
(Schenkels et al., 1995). PRPs are divided into three groups depending on their charge 
and degree of glycosylation. There are acidic, basic and glycosylated basic PRPs 
(Schenkels et al., 1995; Dodds et al., 2005). Acidic PRPs bind with high affinity to 
hydroxyapatite and are found in the acquired enamel pellicle. Functional studies have 
shown that acidic PRPs inhibit crystal growth of calcium phosphate in supersaturated 
solutions (Hay et al., 1979; Lamkin et al., 1993; Dodds et al., 2005). After adsorption to 
hydroxyapatite salivary acidic PRPs can promote the adhesion of several oral bacteria, 
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notably Actinomyces viscosus and Streptococcus gordonii (Gibsons and Hay, 1988; 
Gibbons et al., 1991; Lamkin et al., 1993). 
Glycosylated basic PRPs function as masticatory lubricant and as a 
consequence, oral surfaces like teeth are protected in part from damage caused by 
frictional forces. They also bind to oral bacteria, in particular to Fusobacterium 
nucleatum (Gillece-Castro et al., 1991; Schenkels et al., 1995). The functions of basic 
PRPs are unclear. They bind and precipitate tannins, a dietary constituent with side-
effects that are potentially toxic if not neutralized by salivary proteins (Hagerman and 
Butler, 1981; Yan and Bennick, 1995; Lu and Bennick, 1998). 
b. Statherin 
Another salivary phosphoprotein is statherin which contains many tyrosine 
residues and has two vicinal phosphoserines in its primary structure (Lamkin et al., 
1993; Schenkels et al., 1995). It is secreted by the parotid, submandibular and von 
Ebner's salivary glands. Like PRPs, statherin is also found in the acquired enamel 
pellicle, binds calcium ions and inhibits crystal growth of calcium phosphate and 
calcium carbonate (Lamkin et al., 1993; Schenkels et al., 1995). It has also been 
demonstrated to function as an oral lubricant (Douglas et al., 1991 ). It is capable of 
binding a few oral bacteria such as Porphyromonas gingivalis and Actinomyces 
viscosus (Amano et al., 1994 ). Statherin resembles the acidic PRPs in terms of 
preventing crystal growth formation. In addition, statherin inhibits the spontaneous 
precipitation of calcium phosphate salts. These functions are important for protecting 
the integrity of enamel surfaces. 
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c. MG1 and MG2 
Mucins are secreted by submandibular and sublingual glands (Dodds et al., 
2005). They are highly glycosylated proteins in that 50 to 90% of their dry . weight is 
composed of sugars (Schenkels et al., 1995). Mucins form heterotypic complexes with 
other salivary proteins like slgA and albumin, prevent desiccation and provide 
lubrication. There are two saliva specific types of mucins, the high molecular weight 
mucin MG1 (>106 Da) and the low molecular weight mucin MG2 (200-250 kDa) (Levine 
et al., 1987). MG1 and MG2 are functionally and structurally different (Schenkels et al., 
1995; Dodds et al., 2005). Mucins have a large number of carbohydrate side chains 
which are covalently attached via O-glycosidic linkages of N-acetylgalactosamine to 
serine or threonine (Schenkels et al., 1995). N-linked glycosylation occurs at the Asn-
Xaa-Ser/Thr sequence and is a co-translational process that is catalyzed by 
oligosaccharyl transferase, a protein complex localized in the lumen of the 
endoplasmic reticulum (reviewed by Weerapana and lmperiali, 2006). O-linked 
glycosylation is also termed "mucin-type" glycosylation and is characterized by a-N-
acetylgalactosamine attached to the hydroxyl group of Ser or Thr side chains (reviewed 
by Hang and Bertozzi, 2005). While N-linked glycosylation occurs at a defined 
consensus sequence (Kornfeld and Kornfeld, 1985), no primary amino acid consensus 
sequence has been described for mucin-type glycosylation. MG1 forms a barrier 
against acidic attacks by binding to the tooth surface. It also attaches to the tooth 
pellicle and lubricates the tooth surface and protects the tooth against mechanical wear 
(Dodds et al., 2005). In contrast to MG1, MG2 binds to a large number of oral 
microorganisms including S. mutants (Schenkels et al., 1995; Liu et al., 2000; Dodds et 
al., 2005). Mucins bind to a wide variety of bacterial species, including S. mutants (Liu 
et al., 2000). Both mucins have also been implicated in the protection against viruses 
such as herpes simplex type 1 (Bergey et al., 1993a; Amerongen et al., 2004 ). 
5 
The major roles of mucins are lubrication of the hard and soft tissues in the oral 
cavity and protecting the teeth from abrasive forces. Mucins are also essential for bolus 
formation and swallowing of solid foods. The low levels of saliva and mucins as in 
xerostomic patients cause the tongue and food bolus to stick to the oral mucosa, 
leading to dysphagia. Furthermore, mucins facilitate proper speech by preventing the 
tongue from sticking to the oral mucosal surfaces (Herrera et al., 1993). 
d. Cystatins 
Cystatins are found in various mucosal secretions such as salivary glands and 
lacrimal glands but their concentration varies (Schenkels et al., 1995). For instance, 
cystatin activity in mild gingivitis subjects is about 5 times higher in submandibular 
saliva than in parotid saliva (Henskens et al., 1994 ). They function as cysteine 
proteinase inhibitors, and inhibit several viruses such as herpes simplex virus (Bjorck __ 
et al., 1990; Schenkels et al., 1995). Many cystatins control the proliferation and 
invasion of tumor cells (Sloane and Honn, 1984 ). They are also found in the acquired 
pellicle, bind to hydroxyapatite and inhibit its growth (Rathman et al., 1989). 
e. Histatins 
Histatins are histidine-rich cationic proteins that are low molecular weight and 
are secreted by parotid and submandibular glands. The predominant forms of histatins 
in salivary secretion are histatin 1, histatin 3 and histatin 5 consisting of 38, 32 and 24 
amino acid residues, respectively. Histatin 1, 3 and 5 are precursor components of the 
acquired enamel pellicle and all bind to hydroxyapetite (Lamkin et al., 1993). All these 
histatins exhibit antibacterial as well as antifungal activity. They are capable of killing C. 
albicans in their yeast and mycelial form. As the salt concentration increases the 
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fungicidal, and to a lesser extent the bactericidal activity of histatins decreases which 
shows they are sensitive to ionic strength (Lamkin et al., 1993; Amerongen et al., 
2004 ). Histatin 5, which is formed from proteolysis of histatin 3, is more effective in 
killing blastospores and germ tubes than histatin 1 and 3. This indicates that a 
proteolytic fragment is more anticandidal than the original gene products (Lamkin et al., 
1993). The domain of the histatin 5 that is responsible for the fungicidal activity is 
located in the C-terminal 14 residue moiety of the protein (Helmerhorst et al., 2001 ). 
Histatin 5 acts by entering the fungal cell and association with mitochondria, followed 
by the generation of reactive oxygen species which ultimately kill the fungal cells 
(Helmerhorst et al., 1999; Helmerhorst et al., 2001 ). Blastospore killing is pH 
dependent for histatin 1 and 3 but not for histatin 5, indicating that histatin 1 and 3 are 
fungicidal only under certain conditions. Histatin 1, the only phosphorylated histatin 
inhibits the crystal growth of calcium phosphate salts but does not inhibit its 
spontaneous precipitation (Lamkin et al., 1993). 
f. Lysozyme 
Lysozyme is a muramidase that is widely secreted throughout mucosal tissues. 
It is part of the innate immune system (Schenkels et al., 1995). In the oral cavity 
lysozyme is synthesized by ductal cells (Dawes et al., 1981 ). It exhibits antibacterial 
activity due to its ability to cleave ~ (1-4 )-glycosidic bonds between muramic acid and 
N-acetylglucosamine residues in the peptidoglycan of the bacterial cell wall. The 
concentration of lysozyme has been shown to increase with Candida carriage 
(Schenkels et al., 1995), suggesting there is induced expression due to microbial 
colonization. 
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g. Lactoferrin 
Lactoferrin is produced by various secretory cells such as acinar, lacrymal and 
mammary cells. It is also a major component of the secondary granules in neutrophils 
(Edgerton et al., 2000). It is a cationic peptide which possesses activity against 
bacteria and fungi. The N-terminal 11 amino acids of lactoferricin retain full bactericidal 
properties as well as being active against fungi like C. albicans. Lactoferrin is an 80-
kDa iron binding protein. The iron binding domain of the molecule is located at the 
carboxy terminus (Bellamy et al., 1992a). It deprives microorganisms from iron by 
chelating it. In vitro it shows anti-inflammatory actions as well (Edgerton et al., 2000; 
Amerongen et al., 2004 ). Lactofericcin which spans the N-terminal 40 amino acid 
residues, is liberated upon combined pepsin on trypsin digestion, and may kill bacterial 
activity by forming pores in the cell membrane (Chapple et al., 1998). 
h. Peroxidase 
Lactoperoxidase is a member of the peroxidase enzyme family which is 
secreted into saliva, milk and tears. It catalyzes the oxidation of the thiocyanate ion by 
hydrogen peroxide into hypothiocyanite. By doing so it protects the host cells from 
toxicity of hydrogen peroxide. In addition, the hypothiocyanite ion exhibits antibacterial 
activity. It is also anti-infectious by being active against many viruses including HIV, 
herpes simplex type 1, echovirus and respiratory syncytial viruses (Thomas et al., 
1994; Tenovuo et al., 2002). Furthermore, peroxidases have been shown to inhibit 
dental plaque acid production after sugar exposure through the formation of 
hypothiocyanite and possibly other short lived oxidation products (Tenovuo et al., 
1981 ). 
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i. slgA and lgG 
The main immunoglobulin in human saliva is secretory immunoglobulin A (slgA) 
which differs from plasma lgA since it appears as a dimer (Dawes et al., 1981 ). The 
dimer is composed of two lgA molecules, a J chain and a secretory component (Dawes 
et al., 1981; Schenkels et al., 1995; Dodds et al., 2005). The J chain is synthesized by 
plasma cells in the salivary glands while the secretory component is synthesized by the 
acinar cells (Dawes et al., 1981 ). The main functions of slgA is to inhibit bacterial 
adherence and colonization to oral tissues by blocking surface structures of the 
mucosa from binding bacteria (Herrera et al., 1993; Amerongen et al., 2004 ). 
Besides slgA, whole saliva also contains serum-derived antibodies, mainly lgG. 
lgG antibodies exist in saliva of children as early as the first year of life. The major 
route of entry of lgG antibodies into whole saliva is through the gingival crevice. It is 
assumed that lgG antibodies are produced in response to salivary contacts of mothers 
with their babies during the first year of their life. The ingested microorganisms from the 
mothers' saliva enter the gut and pass through the intestinal mucosa and evoke the 
systemic lgG response (Van Nieuw Amerongen et al., 2004). 
1.3 Xerostomia 
The importance of saliva in controlling the growth of microorganisms is evident 
from the fact that subjects with a reduced salivary flow rate rapidly develop oral health 
conditions that are caused by these microorganisms, such as caries ( caused by acid 
producing bacteria) and candidiasis (caused by fungi). Human saliva has a very crucial 
function in the oral cavity and it is not appreciated until oral health conditions like 
xerostomia (dry mouth) develop. Xerostomia is a clinical disorder and is defined as a 
subjective feeling of dry mouth. In most cases xerostomia is caused by a decrease in 
the flow rate of saliva and is more prevalent in the elderly. It may also be an indicator of 
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systemic disease and exocrine gland dysfunction. The normal flow rate of unstimulated 
whole saliva is 0.3 to 0.5 ml/min. A person with a flow rate of less than 0.1 ml/min is 
considered to have xerostomia. Such low flow rates reflect 60% to 75% of salivary 
gland function impairment. To establish a subject's salivary flow, sialometric 
procedures are used, which are easily accomplished in the office. During such 
procedures, patients are asked to both chew wax and expectorate for a certain period 
of time to determine their stimulated whole saliva flow rate, or just expectorate for the 
same time period without chewing wax to determine unstimulated whole saliva flow 
rate (Sreebny et al., 1987; Herrera et al., 1993). 
There are systemic disorders and diseases that are associated with xerostomia. 
For instance, xerostomia is one of the symptoms of Sjogren's syndrome and some 
other autoimmune diseases. Also, xerostomia is very prevalent (50%) in patients 
suffering from rheumatoid arthritis. Xerostomia is also correlated with certain 
medications and irradiation to the head and neck area (Sreebny et al., 1987; Herrera et 
al., 1993). It is more common in women (25%) than men (16%) with systemic diseases 
(Osterberg et al., 1994 ). 
The symptoms of xerostomia are burning sensation and soreness of the 
mucosa, especially the tongue. Patients may have difficulty with mastication, 
swallowing, speech, and report impairment of taste, ulcers, difficulty with wearing 
dentures, and increase in dental caries. Patients with dry mouth are predisposed to 
mucosal infections, including fungal infection like candidiasis that may not be 
symptomatic and difficult to treat (Sreebny et al., 1987; Herrera et al., 1993). 
1.4 Oral Candidiasis 
Fungal species can be isolated from the healthy oral cavity. Most of these fungi 
belong to the genus Candida, and the most prevalent species is C. albicans. C. 
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albicans is a fungus that can grow in a number of morphological forms, ranging from 
yeast to hyphae. Pseudohyphal forms are also seen. Hyphal forms are invasive and 
pathogenic, while the yeast is considered the commensal non-pathogenic form. C. 
albicans is more frequently found on the dorsum of the tongue, but it can also be found 
on the cheek and tooth surfaces. It has been reported that 20 to 60% of the population 
are oral carriers of C. albicans. C. albicans adhere to complement receptors, various 
extracellular matrix proteins, and specific sugar residues such as galactosides which 
are displayed on the host or bacterial surfaces in the oral cavity. They adhere to 
epithelia, endothelia and phagocytic cells of the host (Cannon et al., 1995). 
Not many C. albicans carriers develop oral cadidiasis. Oral candidiasis results 
from C. albicans overgrowth and penetration of the oral tissues when the host's 
physical and immunological defense system have become compromised due to 
disease or medication. There are many factors that increase an individual's 
susceptibility to oral candidiasis. Some are ill-fitting dentures, antibiotic therapy, AIDS, 
malignancy, impaired granulocyte function and anti-cancer treatments. It is seen in 10 
to 15% of debilitated, elderly people. It is also seen in neonates whose immune 
systems are immature and whose gastro-intestinal microflora has not yet been 
established. Individuals such as organ transplant recipients, cancer patients and 
individuals with AIDS are more common to develop oropharyngeal candidiasis 
(Cannon et al., 1995). 
There are five different types of oral candidiasis. They are pseudomembranous 
candidiasis, chronic atrophic candidiasis, angular cheilitis, acute atrophic candidiasis 
and chronic hyperplastic candidiasis. Pseudomembranous candidiasis is the most 
common form of oral thrush. It is characterized by creamy, white patches on the 
surface of the oral mucosa and the tongue and curd like pseudomembranes at later 
stages. The pseudomembranes can be scraped off to reveal a raw, erythematous 
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base. Acute atrophic candidiasis (antibiotic sore tongue) and chronic hyperplastic 
candidiasis (Candida leukoplakia) are the least common forms of oral candidiasis 
(Cannon et al., 1995). 
1.5 Salivary Anti-candidal Assays 
In order to quantify salivary antifungal activity, a numb~r of assays have been 
developed. Santarpia and coworkers studied the effect of saliva on C. albicans 
blastopore viability and germ tube formation by first lowering the pH of collected 
salivary secretions from 7.4 to 4.5 with acetic acid. Samples were then either boiled or 
not boiled followed by centrifugation and adjustments of the pH of the supernatants to 
4.5, 5, 6 or 7. After a preincubation period of Candida cells with these processed saliva 
samples, the cells were centrifuged, and the cell pellets were resuspended in low ionic 
strength buffer. At each time point, aliquots were removed, serially diluted in potato 
dextrose broth and dilutions were plated onto potato dextrose agar followed by colony 
counting. Using this method, the authors found that parotid secretion, 
submandibular/sublingual secretion and whole saliva all exhibited antifungal activity. A 
preincubation time of one hour was found to be optimal to reveal parotid secretion 
antifungal activity (Santarpia Ill et al., 1992). 
Lin and coworkers further modified the method of Santarpia by using smaller 
volumes of saliva (50 to 100 µI). To test the blastoconidial viability, C. albicans 
organisms were grown to late log phase, and suspended in acetate buffer. The 
incubation mixture contained 5 µI of Candida suspension (3x 106 CFU/ml) and 95 µI of 
saliva. After incubation, the mixture was diluted 100 fold in low ionic strength buffer and 
further incubated, followed by plating on a Sabouraud dextrose agar. The results in this 
assay showed that whole and submandibular-sublingual saliva of healthy individuals' 
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exhibit anticandidal activity and that this activity is reduced in saliva samples from HIV 
infected patients (Lin et al., 1999). 
The above methods involve extensive saliva sample treatments before saliva 
antifungal activities could be demonstrated. Helmerhorst and coworkers developed a 
different assay involving sample dialysis. It is well known that ionic strength has an 
inhibitory effect on the fungicidal activity of many cationic proteins. To study the effect 
of salt on antifungal proteins in parotid secretions, submandibular and sublingual 
secretions were collected and dialyzed with membrane tubing with molecular weight 
cutoffs (MWCO) of 500, 1,000, 10,000 and 25,000. After dialysis, a Candida killing 
assay was performed and treated cells were plated an agar to assess the viability. No 
killing of C. albicans was observed with either undialyzed parotid secretion or parotid 
secretions that had been dialyzed with membrane tubing of MWCO of 500. However, 
cell killing of C. albicans was observed with parotid secretion dialyzed with MWCO of 
1,000 and 10,000 tubing. The authors hypothesized that the observed killing activity 
after dialysis was due to the removal of salt. Indeed, when sodium chloride was added 
to the dialyzed (MWCO 10,000). the fungicidal activity was abolished. The authors also 
investigated the molecular weights of the proteinaceous components that remained in 
the tubing after dialysis. Some of the proteins that were extracted from the gel showed 
antifungal activity. The molecular weights of these proteins, matched those of histatins 
and lysozyme suggesting that these may account for the observed antifungal activity 
(Helmerhorst et al., 2004 ). 
1.6 Broth Microdilution Assay for Cationic Antifungal Peptides 
Recently, Helmerhorst and coworkers also developed a broth microdilution 
assay allowing the rapid identification of fungal pathogens susceptible to naturally 
occurring salt-sensitive cationic antifungal proteins (Helmerhorst et al., 2005). The 
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authors established that 10% Sabouraud dextrose broth is the best medium to support 
fungal growth and at the same allowing the fungistatic activity of histatins to be 
determined. They tested 13 medically important fungi against histatin 1, 3, 5 and P-113 
(comprising residues 3 to 12 of histatin 3 and 5 in an amidated form) in a growth 
inhibition assay. It was discovered that C. glabrata showed a remarkable resistance to 
histatins as well as to some other cationic antifungal peptides (Helmerhorst et al., 
2005). 
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1 . 7 Objective 
Many bacteria and fungi coexist in the oral environment. The multiple 
proteinaceous constituents of saliva are believed to play a crucial role in maintaining 
oral microbial homeostasis. Despite the complex antimicrobial properties of saliva in 
the healthy host, oral organisms such as C. albicans do not vanish and are considered 
part of the commensal flora of the healthy mouth. The relationship between levels of 
individual salivary antifungal components and Candida carriage has been addressed in 
a few studies, but little evidence has been presented indicating that concentrations of 
selected proteins correlate with the oral Candida carrier status. 
The objectives of this study were: 
1. To determine the number and type of fungal cells in whole saliva from 13 
healthy individuals sampled over a 2 to 3 week time interval to identify non-
Candida carriers, low Candida carriers and high Candida carriers. 
2. To investigate the fungistatic activity of parotid secretion collected from two low 
and two high Candida carriers against 6 C. a/bicans strains and 9 other fungi 
including a variety of medically important species. 
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2. MATERIALS AND METHODS 
2.1 Fungal Strains 
The 15 fungal strains that were utilized in this study are summarized in Table 1. 
Fungi were cultured on Sabouraud dextrose agar (SOA) for 48 hours at 30 °C. A 
colony was subcultered in 50% in Sabouraud dextrose broth (SOB) and cultured for 16 
hours at 30 °C to obtain fungal suspensions. Two tubes containing 5 ml of 50% 
Sabouraud dextrose broth and 0.3 mg/I yeast extract (SOB+YE) were inoculated with 
one colony of 15 selected fungal strains picked from an SOA agar plate and incubated 
at 30 °C for 16 hours. 
2.2 Culture Media 
a. Solid Media 
Sabouraud dextrose agar (SOA) powder (55 g) was added to 1 liter of MilliQ 
water. The solution was sterilized at 250 °F for 30 minutes. After the solution was 
cooled to room temperature for 20 minutes, 500 µI chloramphenicol was added to 1 
liter of the solution (final concentration 20 µg/ml). The agar was subsequently poured 
into Petri dishes (Fisher Scientific, Pittsburgh, PA) and allowed to solidify at room 
temperature. 
b. Liquid Media 
Sabouraud dextrose broth (SOA) powder (15 g) was added to 1 liter of MilliQ 
water. This solution is 50% of the original SOB strength. An aliquot of 100 µI of yeast 
extract (3 mg/ml) was added to 1 liter of the solution. The solution was then sterilized at 
250 °F for 30 minutes. 
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Table 1. Fungal Strains Tested in This Study. 
Name of the strain ATCC# 1 RIVM#2 
Candida albicans MYA-2876 n/a 
Candida albicans 10231 n/a 
Candida albicans 90028 n/a 
Candida albicans 90029 n/a 
Candida albicans 44505 n/a 
Candida albicans 32354 n/a 
Candida kefyr 4135 n/a 
Candida krusei 6258 n/a 
Candida parapsi/osis 90018 n/a 
Candida g/abrata 90030 n/a 
Candida glabrata 2001 n/a 
Candida glabrata 64677 n/a 
Cryptococcus neoformans n/a 39231 
Cryptococcus neoformans n/a 42766 
Saccharomyces cerevisiae 204508 n/a 
1ATCC, American Type Culture Collection. 
2 RIVM, Rijks lnstituut voor Volksgezondheid en Milieu. 
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Reference# 
SC5314 
315 
357 
358 
44505 
32354 
311 
355 
356 
359 
2001 
64677 
316 
317 
S288C 
2.3 Saliva Collection 
a. Whole Saliva 
Whole saliva (WS) was collected from 13 healthy subjects ranging in age from 
20-40 years of age. All subjects consented to their participation in the study and 
collections were carried in accordance with approved IRB protocols. Subjects were 
provided with parafilm (1 g) and asked to masticate at a rate of approximately 60 
strokes per minute. Saliva (5 ml) was collected in 50 ml Falcon tubes (Becton 
Dickinson, Franklin Lakes, NJ) chilled on ice. WS of thirteen subjects was collected 2 
to 3 times weekly over a two to three week time interval. One of the subjects' WS was 
also collected every fifteen minutes over 90 minute time period. 
b. Parotid Saliva 
Parotid salivary (PS) secretions were collected under gustatory stimulation. A 
Lashley cup was placed over the Stensen's duct and a negative pressure was applied. 
Subjects were provided with a sour candy for stimulation of parotid salivary secretions. 
Parotid saliva was collected in a 10 ml Falcon tube (Becton Dickinson, Franklin Lakes, 
NJ) chilled on ice. Prior to growth inhibition experiment, PS was filtered using Acrodisc 
syringe filters with a 0.2 µm pore size (Pall Corporation, Ann Arbor, Ml). 
2.4 Determination of the Protein Concentration in Parotid Saliva (PS) 
The protein concentrations in PS samples were determined using the micro 
BCA method (Pierce, Rockford, IL). Working reagent (WR) was prepared according to 
the manufacturer's instructions supplied with the BCA kit. A BSA dilution series was 
prepared ranging from 0-40 µg/ml. From this series, 100 µI was mixed with 100 µI of 
WR in a micro titer plate (Corning Incorporated, Corning, NY). The filtered PS was 
diluted 50 times by adding 20 µI to 980 µI of milliQ water. From this dilution, 100 µI was 
mixed with 100 µI WR in the same micro titer plate. The micro titer plate was covered 
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with plastic (Nalge Nunc International, Rochester, NY), closed with the micro titer plate 
lid, and incubated at 37 °C. After 2 hours, the absorbance of the solutions was 
determined at 560 nm using the Genius microtiter plate reader (Tecan Trading, AG, 
Switzerland). The data were analyzed in Microsoft Excel and the protein concentration 
in the PS samples was determined by comparison to the BSA standard curve. 
2.5 Determination of Whole Saliva Candida Levels 
Two aliquots of 1 ml of collected WS were centrifuged in Eppendorf tubes 
(Fisher Scientific, Pittsburgh, PA) for 20 min at 14,000 g. After centrifugation, the pellet 
in each tube was suspended in 100 µI sterilized phosphate buffer saline (PBS, PH=7.0) 
and plated on two SDA plates containing chloramphenicol. After 48 hrs of incubation at 
30 °C, colonies, representing fungi, were counted. In some cases resuspended pellets 
were also plated on Chromagar (Hardy Diagnostics, Santa Maria, CA) to be able to 
distinguish C. a/bicans from other fungal species. Chromagar is a differential culture 
medium that facilitates the isolation and presumptive identification of clinically 
important yeast species, especially from mixed yeast specimens. C. albicans appear 
as medium size, green, smooth, matte colonies with a very slight green halo in the 
surrounding media. Candida tropicalis are medium size, smooth, matte colonies which 
are blue to blue-gray in appearance with a paler pink edge. If a colony is a large, 
spreading, rough, pink with pale pink to white edges, it is Candida krusei. 
2.6 Determination of the Antifungal Activity of Parotid Salivary Secretions 
The optical density (OD) of fungal cultures (cultured in 5 ml of 50% SDB+YE for 
sixteen hours at 30°) was measured at 620 nm using the Cary 50 spectrophotometer 
(Varian, Palo Alto, CA). Suspensions were diluted with 50% SOB until the OD was less 
than 0.8 and the OD of the original culture was calculated (ODstock)-From this 
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suspension an aliquot was added to 5 ml of SDB+YE yielding a cell density of 2x 104-
2x 105 CFU/ml. The aliquot added was calculated by the following formula: 25/ODstock 
µIs. Using the multichannel pipette, 80 µI of sterilized water was added to wells of 
columns 1-11 of a 96 wells micro titer plate (Corning Incorporated, Corning, NY). 20 µI 
of 50 % SDB+YE was added to the first column. An aliquot of 160 µI of filtered PS was 
added to the twelfth column. From this column, 80 µI of PS was serially diluted in water 
until the third column and the last 80 µI was discarded. An aliquot of 20 µI of the diluted 
fungal suspension was added to each well in the microtiter plate except the first 
column. The first column containing broth only served as a sterility control whereas the 
second column to which no PS protein was added served as a growth control. The 
microtiter plate was covered with plastic (Nalge Nunc International, Rochester, NY), 
closed with a lid and incubated at 30 °C for 24 hours. After the 24 hours, the plates 
were centrifuged in a Sorvall RT6000B centrifuge for 1 minute at 3,500 rpm (Dupont, 
New York, NY) and the cells were re-suspended with a multichannel pipette set at 50 
µI. The OD at 620 nm was subsequently read using the Genius micro titer plate reader. 
The data were exported to Microsoft Excel and the IC50 values were determined from 
the growth inhibition curves in which the 10109 of the PS protein concentration was 
plotted against the OD620 values corrected for absorbance by broth only (average of 
absorbance in the first column). 
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3.RESULTS 
3.1 Oral Candida Carriage in Thirteen Subjects 
The Candida levels in WS of 13 subjects were determined. Subjects 1 to 6 were 
sampled 10 times over a three week time interval. Subjects 6 to 13 were sampled 6 
times over a two week time period. The number of colony forming units per ml 
(CFU/ml) was determined by plating. Table 2 represents the average number of 
colonies in the two 1 ml aliquots of WS per subject and the experimental error. 
Subjects 7, 8, 11 and 12 never showed signs of Candida carriage, as their saliva 
culture were negative on all sampling occasions. These subjects were therefore 
considered non-carriers (NC). Subjects 1, 2, 6, 9 and 10 had zero viable fungal counts 
on most of the days their saliva samples were analyzed (Figure 1 ). Each of these 
subjects had at most three CFU/ml, except subject 10, who had 15 CFU/ml on one day 
and zero colonies on all other sampling days. These subjects were considered low 
carriers (LC). Subjects 3, 4, 5 and 13 had colonies in their saliva on all sampling 
occasions and never had zero colonies. Therefore, these four subjects were 
considered high carriers (HC). 
The four Candida carriers showed considerable fluctuations in their Candida 
levels between days. To visualize these fluctuations, data in Table 2 were plotted in 
Figure 1. Subject 4 showed a high number of colonies on one particular sampling day 
(day 6). This was not due to an experimental error since the duplicate sample also 
contained similar high Candida levels. Interestingly, two days after, the number of 
colonies in this subject had decreased from 727 to 63 CFU/ml. Subject 13 also 
harbored a high number of Candida cells in its saliva, and the absolute values showed 
noticeable variations between days, ranging from 327 to over 1000 CFU/ml. The 
variation observed in 2 subjects was in the high CFU/ml range (up to 1000 CFU/ml) 
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whereas all the other subjects ranged from 0-160 CFU/ml. Therefore, in Figure 1 B, 
data are plotted excluding subjects 4 and 13 to better visualize the fluctuations in 
Candida levels in the other carriers. This representation shows that the other carriers 
also exhibited fluctuations in Candida levels, but the fluctuation was not as dramatic as 
seen in subjects 4 and 13. 
22 
Table 2. Candida carriage (CFU/ml) in WS from 13 subjects ampled over a 2 to 3 week time interval. 
Subject Number/Carrier status 
Sampling 1 2 3 4 5 6 7 8 9 10 11 12 13 
Day LC3 LC HCb HC HC LC NCC NC LC LC NC NC HC 
1 1±0 3±2 19.5±2.5 137.5±2.5 52.5±13.5 0 0 0 2±1 15±3 0 0 327±96 
3 0 0 0 0 0 0 817±75 
4 0.5±0.5 1 158±7 220±10 5.5±1.5 3±3 
5 0 0 0.5±0.5 0 0 0 344.5±8.5 
6 0 0 51.5±20.5 727±127 12.5±1.5 0 
8 1.5±0.5 0.5±0.5 25.5±1.5 63±9 7.5±0.5 0 
10 0 0 0 0 0 0 >1000 
N 11 0 0 15.5±0.5 62±9 59±2 0 v.) 
12 0 0 0 0 0 0 >1000 
13 0 0 19.5±1.5 38±2 25±1 0 
14 0 0 88±3 115.5±9.5 14±3 0 
15 0 0 0 0 0 0 335±20 
18 0 92±5 63.5±23.5 18±3 0 
20 0 17.5±2.5 40±6 8±5 0 
22 0 126.5±9.5 88.5±14.5 2±1 0.5±0.5 
a LC, low carrier 
b HC, high carrier 
c NC, non carrier 
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Figure 1. Variation in Candida levels over time and between subjects. Whole saliva 
was collected under stimulated conditions, 1 ml was centrifuged for 20 min at 14,000 x 
g, the pellet was suspended in 100 µI PBS and plated on Sabouraud dextrose agar 
containing chloramphenicol. After 48 hrs of incubation at 30 °C, colonies, representing 
fungi, were counted. Six to ten samples were collected over a 2-3 week time interval. 
A, results obtained with 13 subjects. 8, results excluding subjects 4 and 13. 
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3.2 Variation in Candida Levels in One Subject over a 90 Minute Time Interval 
It was hypothesized that the observed variations in Candida levels within one 
subject may be due to subtle fluctuations in a subject's immunological defense. This for 
example could be due to daily stressors or stress associated with upcoming exams. To 
investigate this, it was first assessed whether the variation was truly dependent on the 
day of the week and not on the sampling occasion. To investigate potential variation in 
samples taken at separate occasions, seven samples were collected from one subject 
(#3, carrier) every fifteen minutes over a 90 minute time interval. The number of colony 
forming unit per ml (CFU/ml) were determined by plating. At t=0, the subject had below 
50 colonies, while at t=30 minutes, 160 colonies were counted. Over the 90 minute 
time interval, Candida counts varied between 25 and 160 colonies. This result 
indicated that fluctuations in Candida carriage within subjects as shown in Figure 2 
may well be due to the sampling occasion . Due to this observation, further studies on a 
potential physiological basis for variations in Candida levels were abandoned. 
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Figure 2. Variation in Candida levels in one subject sampled over a 90 minute time 
interval. WS was collected every fifteen minutes under stimulated conditions. A 1 ml 
aliquot was centrifuged and the pellet was suspended in 100 µI of PBS and plated on 
SDA containing chloramphenicol. After 48 hrs of incubation at 30 °C, colonies, 
representing fungi, were counted. 
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3.3 Types of Fungi Present in WS of the High Carriers 
To asses which type(s) of fungi were present in WS of three of the four high 
carriers, their whole saliva pellets were plated on Chromagar plates. The principle of 
this medium is the use of the chromogenic substrates revealing metabolic enzymes. 
For example, green colored colonies, revealed by a chromogen, indicate the presence 
of the enzyme N-acetyl-galactosaminidase and are presumptively identified as C. 
albicans. C. a/bicans form medium size, green, smooth, matte colonies with a very 
slight green halo in the surrounding media. WS from subjects 3, 4 and 5 was plated. 
The results confirmed the carrier status of these individuals and further showed that the 
fungal species colonizing their oral cavities was in all cases C. albicans (Figure 3). The 
fourth carrier (#13) was not available for this experiment. 
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Figure 3. Determination of Candida species in three of the four high carriers. Aliquots 
of 1 ml of WS were plated on ChromAgar. ChromAgar contains a chromogen that 
allows for the specific identification of C. albicans (green colonies). Note that all three 
carriers harbored C. albicans in their saliva. 
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3.4 Antifungal Activity of Parotid Secretion of High and Low Carriers 
After establishing Candida carriage in WS of the enrolled subjects, the 
antifungal activity of PS of four of these subjects (1, 2, 3 and 5) was assessed. Two of 
the selected subjects (Subjects 1 and 2) were low Candida/ carriers containing on 
average 2 CFU/ml in their saliva whereas subjects 3 and 5 were high Candida/ carriers 
containing on average 40 CFU/ml (Table 2). Antifungal activities of PS secretions were 
assessed by determining the IC50 values toward 15 medically important fungi. The IC50 
value represents the amount of the total PS protein required for 50% growth inhibition. 
Parotid saliva from all four subjects showed potent growth inhibitory activities against 
most of the tested fungi, but no clear differences were observed in activities of PS 
collected from low carriers or high carriers (Table 3). 
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3.5. Differential Activity of PS Toward Various Fungal Strains 
The fungal strains evaluated belonged to three different fungal genera 
(Candida, Cryptococcus and Saccharomyces). Among the Candida species, six strains 
of C. albicans, one strain of C. kefyr, one of C. krusei, one C. parapsi/osis and three 
strains of C. glabrata were tested. Two Cryptococcus neuformans strains and one 
Saccharomyces cerevisiae strain were also evaluated (Table 1 ). In Figures 4A to 7 A, 
the averages of the obtained IC50 values are plotted. In Figure 48 to 78, the average 
ICso values with the standard deviation are plotted. In Table 3, the values used to 
generat~ graphs 4 to 7 were shown. Note that in some cases the true IC50 value could 
not be established (indicated with a > sign), since no growth inhibition was observed at 
at the highest protein concentration evaluated (the protein concentration in the 
undiluted PS sample). Interestingly PS of all subjects showed a clear trend of being 
least effective towards C. albicans. The remarkably low sensitivity C. albicans was 
observed with PS from all subjects, regardless of their lower high carrier status. Only 
one of the C. a/bicans strains (C. albicans 358) displayed lower IC50 values than the 
other five C. a/bicans strains. However, its IC50 value was still higher than for the other 
fungi evaluated. The other fungi tested displayed IC50 values ranging from 14 to 120 
µg/ml, except for C. glabrata 359 in subject 2, which showed an unexpectedly high ICso 
value (ICso = 695 µg/ml). Among the non-albicans species, C. glabrata 359 was the 
least sensitive. The data clearly demonstrate differential fungistatic activities of PS 
toward different fungi with C. albicans being the least sensitive. 
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Table 3. IC50 Values of Fungal Strains for Parotid Secretion Collected from Four Individuals 1 
Candida Strains Subject 1 (LC} Subject 2 (LC} Subject 3 (HC} Subject 5 (HC} 
C. albicans SC5314 >1151 ± 371 >3143 ± 833 >1083 ± 433 >1319 ± 46 
C. albicans 44505 933 ± 104 1640 ± 814 528 ± 252 > 812 ± 48 
C. albicans 32354 890 ± 189 >2878 ± 1084 >770 ± 115 >1022 ± 345 
C. albicans 315 >709 ± 469 >2481 ± 1489 287 ± 113 >826 ± 396 
C. albicans 357 >1086 ± 425 >3143 ± 833 >729 ± 532 >525 ± 177 
C. albicans 358 270 ± 87 613 ± 175 170 ± 82 170 ± 35 
C. glabrata 359 168 ± 43 695 ± 502 118 ± 52 120 ± 53 
C. glabrata 2001 40 ± 11 84 ± 32 37 ± 12 31 ± 22 
C. glabrata 64677 61 ± 29 39 ± 5.1 102 ± 80 58 ± 19 
C. pseudotropicalis 311 53 ± 16 36 ± 8.9 58±29 87 ± 55 
Cr. neoformans 316 30 ± 13 23 ± 2.9 34 ± 1.5 26 ± 6 
Cr. neoformans 317 32 ± 7.6 25 ± 2.8 32 ± 1.5 27 ± 2 
C. krusei 355 22 ± 7.0 15 ± 4.8 19 ± 5.5 13 ± 1.5 
C. parapsilosis 356 34 ± 18 22 ± 6.8 19 ± 2.2 22 ± 2.5 
S. cerevisiae S288C 41 ± 15 29 ± 9.0 18 ± 5.6 14 ± 6.1 
For values indicated with a > sign the IC50 exceeded the protein concentration in the PS sample. 
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Figure 4-7. Assessment of the fungistatic activity of parotid saliva from four subjects 
against 15 medically important fungi. Data represent the average (A) and average ± 
SD (B) of three to five independent experiments. Figure 4, data obtained with PS 
secretion from subject 1 (low-carrier); Figure 5, subject 2 (low-carrier); Figure 6, subject 
3 (high-carrier); Figure 7, subject 5 _(high-carrier). Note: no significant differences 
between low and high carriers with respect to antifungal activities but significant 
differences in susceptibilities between strains. 
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4. DISCUSSION 
4.1 Candida Colonization of the Oral Cavity 
An important aspect of our study was focused on oral Candida carriage. 
Candida cells present in oral fluid represent free suspended Candida cells in the 
planktonic growth form. From the rate of swallowing and the doubling time of C. 
albicans in saliva (Lenander-Lumikari et al., 1995) it can be calculated that such 
suspended Candida cells in WS represent shedded cells that had originally grown in 
biofilms. The mouth provides a large number of diverse surfaces that can facilitate 
Candida colonization, such as the soft shedding tissues of the buccal mucosa and the 
tongue and the hard non-shedding surfaces of the teeth. C. albicans, the most 
adherent and pathogenic Candida species, utilizes a variety of mechanisms to adhere 
to human tissues. The cell wall of C. albicans is composed of five different layers. It 
includes an outer fibrillar layer followed, in order, by zones rich in mannoprotein, 
glucan, glucan-chitin, and mannoprotein (Fukazawa et al., 1997). When adhering to 
tissues, the strongest mechanism of adherence involves the mannoprotein adhesins in 
the C. albicans cell wall. Mannoproteins are glycosylated proteins that can bind to 
epithelial surfaces either via its protein parts or glycsolyated regions. The protein 
moiety adheres by acting either as a lectin-like ligand recognizing sugar epitopes on 
the epithelial cell surface or by binding to the tripeptide Arg-Gly-Asp (RGD) ligands. In 
addition, cell surface hydrophobicity plays an important role in the Candida adherence 
process by providing hydrophobic interactions that turn the initial attachment between 
the yeast and a surface into a strong bond. Adhesion of C. albicans to the tooth surface 
occurs through binding to either the acquired enamel pellicle or oral microorganisms 
that represent the early tooth colonizers such as several streptococci (Streptococcus 
gordonii, Streptococcus oralis). The acquired enamel pellicle is composed of salivary 
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proteins such as amylase, lysozyme, bacterial glucosyltransferases and glucans, 
albumins, immunoglobulins, cystatins, PRPs, and lactoferrin. It has been described that 
PRPs in enamel pellicle can act as receptors for both C. albicans adhesins and 
streptococci. Therefore, C. albicans can either directly attach to PRPs bound to enamel 
or to PRPs attached to streptococci's which were bound to the acquired enamel 
pellicle. (Cannon et al., 1995; O'Sullivan et al., 2000; Jabra-Rizk et al., 2001; Cannon 
et al., 2005). After adhesion to epithelial celis or tooth structures, Candida multiplies if it 
withstands activities aimed at its removal from the oral cavity. Such activities involve 
the antifungal action of salivary components causing Candida cell growth inhibition and 
cell killing. In addition, shearing forces resulting from lip and tongue movements 
represent a natural cleansing activity and release attached cells into saliva followed by 
swallowing. This complex balance between the success of oral Candida colonization 
and multiplication and host antifungal factors will determine the oral Candida carrier 
status of an individual. 
4.2 Candida Carriage 
Oral Candida carriage has been addressed in a relatively large number of 
investigations (Cannon et al., 1995; Navazesh et al., 1995; Nikawa et al., 1998; 
Cannon et al., 2001; Epstein et al., 2000; Sundstrum et al., 2002; Wang et al., 2006). 
For instance, Sugimoto and coworkers (2006) examined Candida carriage in elderly 
people matched for age, sex and type of denture prosthesis. The authors reported that 
84% of such elderly subjects carried C. albicans in their saliva. Significantly higher 
numbers of Candida colony-forming units were observed in the 80-91 year-old group 
and the 70-79 year-old group than in the youngest age group (age 65-69) suggesting 
that Candida carriage increases with age. The mean colony forming unit counts in the 
partial denture and full denture groups were significantly higher than that in the group 
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wearing no dentures (Sugimoto et al., 2006). Qi and coworkers (2005) examined 
Candida carriage in healthy individuals ranging in age from neonates to about 20 years 
old. The authors reported that the highest frequency of carriage of yeast (49.1 %) and 
C. albicans (40.1%) was in the primary dentition group. In this young group of subjects, 
with increasing age, the frequency of C. albicans decreased from 40.4% to 27.5% (Qi 
et al., 2005). Our study focused on oral Candida carriage in the age group of 20-40 
year. We found that 38% of the subjects examined (5/13) were low carriers and 31 % 
(4/13) were high Candida carriers, such that in total 79% of the participating subjects 
were harboring C. albicans in their WS. While these numbers are in the high range as 
compared to published data (Cannon et al., 1995; Navazesh et al., 1995), it is feasible 
that by distinguishing between low and high carriers and by plating a concentrated 
aliquot of WS we have captured more carriers than in previous studies. In addition, the 
total number of enrolled subjects (13) is rather small as to extend our conclusions to be 
a definite measure for Candida carriage in this age group. 
Usually, Candida carriage is assessed by the determination of Candida counts 
in WS or in scrapings collected from the buccal epithelium. In our study Candida levels 
were determined in WS, facilitating quantitation and comparisons between subjects by 
expressing the number of cells per ml of WS fluid. As indicated above, cells present in 
WS mainly represent detached cells that had grown on solid oral surfaces. The current 
project was aimed at the determination of oral Candida carriage among thirteen healthy 
subjects and to determine the variation in their carriage status over a two to three week 
time interval. From the thirteen subjects examined, four were high carriers as defined 
by having colonies on all sampling occasions and never having zero colonies, five were 
low carriers as defined by having occasionally a few CFU/ml, and four were non 
carriers as their saliva cultures were negative on all sampling occasions. Interestingly, 
in the carrier groups, the absolute levels of Candida carriage showed quite some 
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variation over the 2-3 week period. It was originally hypothesized that the individual 
variation observed could be due to subtle variations in the subject's health status, or 
daily stressors. If so, this would imply that the Candida carriage status and absolute 
Candida carriage counts could be exploited to monitor subtle changes in the microbial 
defense system of the host. While this was an interesting proposition, the fact that the 
Candida counts in one host, sampled over a 90 minute time interval, also showed 
extensive fluctuations indicated that other factors not related to host defense are at the 
base of the observed variations. Considering that WS Candida cells are shedded cells, 
the variation is likely to vary considerably depending on tongue and cheek movements. 
Our studies have pointed out that reported absolute Candida counts in the literature 
should be interpreted with caution. An additional interesting observation we made was 
that despite fluctuations in the carrier groups, the non-carriers maintained their non-
carrier status during the entire interval of examination. It remains to be established if 
non-carriers truly harbor zero Candida cells (are uncolonized) or whether they harbor 
less than 1 C. albicans cell per ml of WS (non-detectable with the culturing approaches 
followed). 
4.3 Parotid Saliva Antifungal Activity 
The second aim of our studies was to investigate the antifungal activities 
associated with parotid secretions, a major salivary secretion containing a number of 
proteins with strong in vitro antifungal efficacy. The proteins of whole saliva in humans 
are derived mainly from the parotid, submandibular, sublingual and minor mucous 
gland secretions. Under unstimulated conditions, the parotid glands contribute 
approximately 25% to the WS fluid volume, the submandibular/sublingual glands about 
67% and the minor mucous salivary glands about 8% (Schneyer, 1956a; Dawes and 
Wood, 1973a). At high stimulated flow rates, parotid saliva may constitute up to 49% of 
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whole saliva (Shannon, 1962) indicating that it contributes significantly to the total 
volume. Therefore, investigating PS antifungal activities is important to gain insight into 
the overall antifungal activities in the oral cavity. 
Histatins, lysozymes, lactoferrin and lactoperoxidase are produced by parotid 
gland and exhibit antifungal activity (Jainkittivong et al., 1998; Lamkin et al., 1993; 
Schenkels et al., 1995). In our study, the antifungal activity of filtered PS of four 
subjects was assessed against 15 medically important fungi. Parotid saliva of all four 
subjects showed potent growth inhibitory activities against most of the tested fungi by 
having low IC50 values. Interestingly, PS of all subjects showed a trend of being least 
effective towards C. albicans. This result suggests a remarkable insensitivity of C. 
albicans for the fungistatic effects of PS proteins. This was true for PS collected from 
low as well as from high Candida carriers. While it can be speculated that the low PS 
activity toward C. albicans is a factor in the successful colonization of the oral cavity, 
our initial observations suggest that there is no direct evidence for a relationship 
between the extent of colonization and PS activity. In this respect it will also be of 
interest to investigate PS activity in non-carriers. If their PS activity towards C. albicans 
is as low as in the carrier groups, then the influence of PS on C. albicans colonization 
may need to be reconsidered. Nevertheless the striking difference in activity of PS 
toward different fungal species is worthy of further investigation. 
Further research should be focused on the determination of the antifungal 
components of PS. It would be of interest to determine if the component is inactivated 
by boiling. If so, this would indicate that the activity of the component is conformation 
dependent since boiling unfolds larger proteins. Furthermore, it would be of interest to 
determine the size of the protein, which could be achieved by filtration or dialysis using 
dialysis tubing with various molecular weight cut-off (MWCO). Separation of proteins in 
PS can be achieved by various chromatographic approaches including anion-
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exchange, cationic-exchange or RP-HPLC. Antifungal susceptibility testing of individual 
proteins isolated from PS may lead to the elucidation of protein(s) that display similar 
differential activities towards fungal species as described in this study for PS. 
The data obtained in this study clearly point out that carrier status occurs 
frequently and can be observed in otherwise healthy subjects. The data also clearly 
show that the biology of the oral environment can definitely support a non-carrier status 
and that carrier status (low or high) cannot be differentiated based on antifungal 
activities of PS. Regardless of the carrier status, this is the first time that substantial 
differences are reported in the susceptibilities of different fungal strains to PS. The 
marked lower sensitivity of C. albicans may explain the predominance of this fungal 
species as an oral colonizer and in causing oral candidiasis in the 
immunocompromised host. 
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